Microtek Medical Receives Early Termination of Hart-Scott-Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab
14 9월 2007 - 6:23AM
PR Newswire (US)
ALPHARETTA, Ga., Sept. 13 /PRNewswire-FirstCall/ -- Microtek
Medical Holdings, Inc. (NASDAQ:MTMD) announced today that it has
received early termination of the waiting period under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended,
in connection with Ecolab Inc.'s pending acquisition of Microtek
Medical Holdings, Inc. The Boards of Directors for both companies
have unanimously approved the transaction, which is expected to
close during the fourth quarter of 2007. About Microtek Medical:
Microtek Medical is a leading manufacturer and supplier of
innovative product solutions for patient care, occupational safety
and management of infectious and hazardous waste for the healthcare
industry. Headquartered near Atlanta, Georgia, the Company offers
an extensive line of infection control, fluid control and safety
products, such as disposable equipment and patient drapes, which
are marketed to healthcare professionals through multiple channels,
including direct sales, original equipment manufacturers ("OEM's")
and private label arrangements. Microtek Medical's goal is to
provide healthcare professionals with innovative product solutions
that encompass a high-level of patient care and prevention of cross
infection in operating rooms and ambulatory surgical centers
worldwide. For further information, visit
http://www.microtekmed.com/. About Ecolab Inc: With sales of $5
billion and more than 13,000 sales-and-service associates, Ecolab
Inc. (NYSE:ECL) is the global leader in cleaning, sanitizing, food
safety and infection prevention products and services. Ecolab
delivers comprehensive programs and services to the foodservice,
food and beverage processing, healthcare, and hospitality markets
in more than 160 countries. More news and information is available
at http://www.ecolab.com/. Important Information: The definitive
proxy statement that Microtek Medical plans to file with the
Securities and Exchange Commission and mail to its shareholders
will contain information about Microtek Medical, the proposed
merger and related matters. SHAREHOLDERS ARE URGED TO READ THE
PROXY STATEMENT CAREFULLY WHEN IT IS AVAILABLE, AS IT WILL CONTAIN
IMPORTANT INFORMATION THAT SHAREHOLDERS SHOULD CONSIDER BEFORE
MAKING A DECISION ABOUT THE MERGER. In addition to receiving the
proxy statement from Microtek Medical by mail, shareholders will be
able to obtain the proxy statement, as well as other filings
containing information about Microtek Medical, without charge, from
the Securities and Exchange Commission's website
(http://www.sec.gov/) or, without charge, from Microtek Medical at
http://www.microtekmed.com/. This announcement is neither a
solicitation of a proxy, an offer to purchase nor a solicitation of
an offer to sell shares of Microtek Medical. Microtek and its
directors and officers and other members of its management and
employees may be deemed to be participants in the solicitation of
proxies in respect to the proposed transaction. Information
regarding Microtek's directors and executive officers is detailed
in its proxy statements and annual reports on Form 10-K, previously
filed with the SEC, and the definitive proxy statement relating to
the proposed transaction, when it becomes available. Actual Results
Could Differ From Forward-Looking Statements: This Press Release
contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Such statements include, but are not limited to,
statements regarding the completion and anticipated timing of the
acquisition transaction. Such statements are subject to certain
factors, risks and uncertainties that may cause actual results,
events and performance to differ from those referred to in such
statements. These risks include, without limitation, the failure to
satisfy the conditions to completion of the acquisition transaction
and the risk factors included in the Company's Annual Report on
Form 10-K for the year ended December 31, 2006 filed with the
Securities and Exchange Commission. The Company does not undertake
to update its forward-looking statements to reflect future events
or circumstances. DATASOURCE: Microtek Medical Holdings, Inc.
CONTACT: Dan R. Lee, President & CEO, or Jerry Wilson, CFO, or
John Mills, Investor Relations, , all of Microtek Medical Holdings,
Inc., 1-800-476-5973 Web site: http://www.microtekmed.com/
http://www.ecolab.com/
Copyright
Microtek Medical (NASDAQ:MTMD)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Microtek Medical (NASDAQ:MTMD)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024